首页> 外文期刊>Journal of Taibah University Medical Sciences >Association of serum free IGF-1 and IGFBP-1 with insulin sensitivity and insulin secretory defects in Bangladeshi type 2 diabetes mellitus
【24h】

Association of serum free IGF-1 and IGFBP-1 with insulin sensitivity and insulin secretory defects in Bangladeshi type 2 diabetes mellitus

机译:孟加拉国2型糖尿病患者血清IGF-1和IGFBP-1与胰岛素敏感性和胰岛素分泌缺陷的关系

获取原文
           

摘要

Objectives Serum free insulin like growth factors-1 (IGF-1) and insulin like growth factor binding protein-1 (IGFBP-1) may have an association with insulin resistance and B-cell secretory dysfunction. Present study is undertaken to explore the independent association of IGF-1 and IGFBP-1with two basic defects in type 2 diabetic patients in a Bangladeshi population. Methods Sixty eight type 2 diabetes mellitus (DM) subjects are studied along with age-, sex- and BMI-matched 61 healthy controls without family history of diabetes or prediabetes. Insulin, free IGF-1 and IGFBP-1 are measured by the standard ELISA method. Insulin secretory capacity (HOMA B) and insulin sensitivity (HOMA S) are calculated using fasting glucose and fasting insulin by HOMA-CIGMA software. Results Fasting free IGF-1 and IGFBP-1 levels are not significantly different between the study groups. But the level of free IGF-1 is significantly higher ( p =0.03) in type 2 DM subjects compared to controls in the low BMI group (BMI?23). In stepwise multiple regression analysis, positive association of HOMA B with free IGF-1 is evident. Similarly positive association of HOMA B and HOMA S with IGFBP-1 is shown in different models. In the same analysis, both free IGF-1 and IGFBP-1 are inversely associated with fasting insulin in different models of stepwise multiple regression analysis. Conclusion Both IGF-1 and IGFBP-1 are negatively associated with fasting insulin levels. Moreover B-cell secretory dysfunction is positively associated with IGF-1 and both B-cell secretory dysfunction and insulin sensitivity are also positively associated with IGFBP-1 in type 2 diabetic patients.
机译:目的无血清胰岛素样生长因子-1(IGF-1)和胰岛素样生长因子结合蛋白-1(IGFBP-1)可能与胰岛素抵抗和B细胞分泌功能障碍有关。目前的研究是为了探索IGF-1和IGFBP-1与孟加拉国人群2型糖尿病患者的两个基本缺陷的独立联系。方法研究了68位2型糖尿病(DM)受试者,以及与年龄,性别和BMI匹配的61名健康对照者,他们没有糖尿病或糖尿病前期家族史。胰岛素,游离IGF-1和IGFBP-1通过标准ELISA方法进行测量。使用空腹血糖和空腹胰岛素通过HOMA-CIGMA软件计算胰岛素分泌能力(HOMA B)和胰岛素敏感性(HOMA S)。结果研究组之间的空腹游离IGF-1和IGFBP-1水平无显着差异。但是,与低BMI组(BMI?23)的对照组相比,在2型DM受试者中游离IGF-1的水平明显更高(p = 0.03)。在逐步多元回归分析中,显而易见HOMA B与游离IGF-1呈正相关。类似地,在不同模型中还显示了HOMA B和HOMA S与IGFBP-1的正相关。在同一分析中,在不同的逐步多元回归分析模型中,游离IGF-1和IGFBP-1与空腹胰岛素呈负相关。结论IGF-1和IGFBP-1均与空腹胰岛素水平呈负相关。此外,在2型糖尿病患者中,B细胞分泌功能障碍与IGF-1正相关,并且B细胞分泌功能障碍和胰岛素敏感性也与IGFBP-1正相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号